Jack Ho Wong received his PhD degree in biochemistry from the Chinese University of Hong Kong in 2005. He serves as a research associate in the Faculty of Medicine and Shenzhen Research Institute, CUHK. He has worked on defense proteins/peptides for over 10 years. His research encompasses: (i) antimicrobial peptides and (ii) antitumor proteins/peptides. He has published more than 80 papers in peer-reviewed journals.

1. Mechanisms of antifungal (Candida spp (biofilm formation) and Trichophyton mentagrophytes), antibacterial (methicillin-resistant Staphylococcus aureus, Helicobater pylori) and antiviral (HIV-1) effects of various antifungal peptides and proteins derived from mammals (cathelicidin and its derivatives, defensins and lactoferrin and its derivatives), plants and fungi and Chinese medicines; 2. Mechanisms of anticancer (breast cancer and colon cancer) effects of fragments of defensin and cathelicidin and other proteins (ribosome inactivation proteins and lectins); 3. To develop novel antimicrobial agents by modifying existing peptides. 4. Study on inhibitors of advanced glycation end-products (AGEs) from Chinese medicines.